Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Condition(s):Breast CancerLast Updated:November 29, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:November 29, 2022Completed
Condition(s):LymphomaLast Updated:April 23, 2019Terminated
Condition(s):Bone Pain in Stage I – III Breast CancerLast Updated:January 30, 2018Completed
Condition(s):Bone PainLast Updated:October 22, 2020Terminated
Condition(s):Early-stage Breast CancerLast Updated:March 23, 2023Active, not recruiting
Condition(s):Breast Cancer; Filgrastim Adverse ReactionLast Updated:February 20, 2024Not yet recruiting
Condition(s):Bone Pain; Breast Carcinoma Metastatic in the BoneLast Updated:December 15, 2023Recruiting
Condition(s):Stem Cell Transplant ComplicationsLast Updated:February 2, 2024Not yet recruiting
Condition(s):Cancer Induced Bone Pain; Secondary Malignant Neoplasm of Bone; Toxicity Due to Radiotherapy; PainLast Updated:June 23, 2021Completed
Condition(s):Vitamin D Deficiency; Chronic Pain Syndrome; Inflammatory ResponseLast Updated:November 6, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.